Alfentanil and the Elimination of Sympathetic Responses to Tracheal Intubation During Rapid Sequence Induction of Anesthesia: A Probability-based Approach

NCT01518608 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia Intubation Complication

Interventions

DRUG: Alfentanil 0.5mg/ml (Rapifen , Janssen-Cilag)

Sponsor

Oslo University Hospital

Collaborators

[object Object]